Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology

Neurology

Volumn 62, Issue 7, 2004, Pages 1148-1155

  Schneider, J A ^a,b   Wilson, R S ^a,b   Bienias, J L ^a,b   Evans, D A ^a,b   Bennett, D A ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN INFARCTION; BRAIN SIZE; CLERGY; COGNITION; CORRELATION ANALYSIS; DEATH; DEMENTIA; DISEASE ASSOCIATION; EDUCATION; FEMALE; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PRIORITY JOURNAL; RISK FACTOR; SENILE PLAQUE; SEX DIFFERENCE;

EID: 1842528072     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000118211.78503.F5     Document Type: Article

References (43)

1. Gearing M, Mirra SS, Hedreen JC, Sumi SM, Hansen LA, Heyman A. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology 1995;45:461-466.
2. Bowler JV, Munoz DG, Merskey H, Hachinski V. Fallacies in the pathologic confirmation of the diagnosis of Alzheimer's disease. J Neurol Neurosurg Psychiatry 1998;64:18-24.
3. Kalaria RN, Ballard C. Overlap between pathology of Alzheimer's disease and vascular dementia. Alzheimer Dis 1999;13(suppl 3):S115-S123.
4. Neuropathology Group of the Medical Research Council Cognitive Function and Aging Study (MRC CFAS). Pathologic correlates of late onset dementia in a multicentre, community based population in England and Wales. Lancet 2001;357:169-175.
5. Heyman A, Fillenbaum GG, Welsh-Bohmer KA, et al. Cerebral infarcts in patients with autopsy-proven Alzheimer's disease. CERAD, part XVIII. Neurology 1998;51:159-162.
6. Lee JH, Olichney JM, Hansen LA, Hofstetter CR, Thal LJ. Small concomitant vascular lesions do not influence rates of cognitive decline in patients with Alzheimer's disease. Arch Neurol 2000;57:1474-1479.
7. Nagy Z, Esiri MM, Jobst KA, et al. The additional effects of additional pathology on the cognitive deficit in Alzheimer's disease. J Neuropathol Exp Neurol 1997;56:165-170.
8. Smith MZ, Nagy Z, Barnetson L, King MF, Esiri MM. Coexisting pathologies in the brain: influence of vascular disease and Parkinson's disease on Alzheimer's pathology in the hippocampus. Acta Neuropathol 2000;100:87-94.
9. Zekry D, Duyckaerts C, Moulias R, et al. Degenerative and vascular lesions of the brain have synergistic effects in dementia of the elderly. Acta Neuropathol (Berl) 2002;103:481-487.
10. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of AD. The Nun Study. JAMA 1997;277:813-817.
11. Esiri MM, Nagy Z, Smith MZ, Barnetson L, Smith AD. Cerebrovascular disease and threshold for dementia in the early stages of AD. Lancet 1999;354:919-920.
12. Schneider, Wilson RS, Cochran EJ, Bienias JL, Evans DA, Bennett DA. Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology 2003;60:1082-1089.
13. Desmond DW, Moroney JT, Paik MC, et al. Frequency and clinical determinants of dementia after ischemic stroke. Neurology 2000;54: 1124-1131.
14. Rockwood K, Howard K, MacKnight C, Darvesh S. Spectrum of disease in vascular cognitive impairment. Neuroepidemiology 1999;18:248-254.
15. Wilson RS, Mendes de Leon CF, Barnes LL, et al. Participation in cognitively stimulating activities and risk of incident AD. JAMA 2002; 287:742-748.
16. Wilson RS, Beckett LA, Barnes LL, et al. Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging 2002;17: 179-193.
17. Bennett DA, Wilson RS, Schneider JA, et al. The natural history of mild cognitive impairment in older persons. Neurology 2002;59:198-205.
18. Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part I. Clinical and neuro-psychological assessment of Alzheimer's disease. Neurology 1989;39: 1159-1165.
19. Bennett DA, Shannon KM, Beckett LA, Goetz CG, Wilson RS. Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating Scale. Neurology 1997;49:1580-1587.
20. McKhann G, Drachmann D, Folstein M, Katzman R, Price D, Stadlan E. Clinical diagnosis of AD. Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on AD. Neurology 1984;34:939.
21. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS International Workshop. Neurology 1993;43:250-260.
22. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the mental state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
23. Goodglass H, Kaplan D. The assessment of aphasia and related disorders. 2nd ed. Philadelphia: Lea & Febiger, 1983.
24. Welsh K, Butters N, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part V: a normative study of the neuropsychological battery. Neurology 1994;44:609-614.
25. Wechsler D. Wechsler Memory Scale-revised manual. San Antonio: Psychological Corp., 1987.
26. Albert MS, Smith LA, Scherr PA, et al. Use of brief cognitive tests to identify individuals in the community with clinically-diagnosed AD. Int J Neurosci 1991;57:167-178.
27. Kaplan E, Goodglass H, Weintraub S. The Boston Naming Test. Philadelphia: Lea & Febiger, 1983.
28. Ekstrom RB, French JW, Harman HH, Dermen D. Manual for kit of factor-referenced cognitive tests. Princeton: Educational Testing Service, 1976.
29. Nelson HE. National Adult Reading Test (NART): test manual. Windsor, UK: NFER Nelson, 1982.
30. Cooper JA, Sagar HJ. Incidental and intentional recall in Parkinson's disease: an account based on diminished attentional resources. J Clin Exp Neuropsychol 1993;15:713-731.
31. Craik F. A functional account of age differences in memory. In: Klix, Hagendorf H, eds. Human memory and cognitive capabilities: mechanisms and performances. Amsterdam: Elsevier Science Publishers BV, 1986:409-422.
32. Smith A. Symbol Digit Modalities Test manual-revised. Los Angeles: Western Psychological, 1984.
33. Benton AL, Varney N, et al. Visuospatial judgment - a clinical test. Arch Neurol 1978;35:364-367.
34. Raven JC, Court JH, Raven J. Standard Progressive Matrices-1992 edition. Raven manual: section 3. Oxford: Oxford Psychologists Press, 1992.
35. SAS Institute. SAS/STAT user guide (version 8). Cary, NC: SAS Institute, 2000.
36. Bennett DA, Wilson RS, Schneider JA, et al. Apolipoprotein E e4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Neurology 2003;60:246-252.
37. Bennett DA, Wilson RS, Schneider JA, et al. Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology 2003;60:1909-1915.
38. Price TR, Manolio TA, Kronmal RA, et al. Silent brain infarction on magnetic resonance imaging and neurological abnormalities in community-dwelling older adults. The Cardiovascular Health Study CHS Collaborative Research Group. Stroke 1997;28:1158-1164.
39. Akiyama H, Garger S, Barnum S, Bradt B, et al. Inflammation and Alzheimer's disease. Neurobiol Aging 2000;21:383-421.
40. Perry G, Nunomura A, Hirai K, Takeda A, Aliev G, Smith M. Oxidative damage in Alzheimer's disease: the metabolic dimension. Int J Dev Neurosci 2000;18:417-421.
41. Selkoe DJ. The genetics and molecular pathology of Alzheimer's disease. Roles of amyloid and the presenilins. Neurol Clin 2000;18:903-922.
42. Sparks DL. Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease? Ann NY Acad Sci 1997;826:128-146.
43. Farkas E, De Vos RA, Jansen Steur EN, Luiten PG. Are Alzheimer's disease, hypertension, and cerebrocapillary damage related? Neurobiol Aging 2000;21:235-243.